FOLH1 and neoplasm: 177Lu-Ibu-DAB-PSMA, the radioligand equipped with a positively charged diaminobutyric acid as a linker entity, showed well-balanced plasma protein-binding properties and, as a consequence, high tumor accumulation and retention but efficient clearance from the blood pool, resulting in high tumor-to-blood AUC ratios.